Visiting from the US? Discover Helixafe, our Cancer Driver Interception program →
EN
Talk to an expert

HELIXAFE

Cancer driver interception

Explore

Stem cell banking

Cord blood and adipose tissue

Explore

BIOXPACE

Healthy longevity

Explore

CELLSKILLS

Stem cells & exosomes

Explore

ULTRANIPT

Prenatal & neonatal genomics

Explore

NGTX

Food supplements

Explore

Not sure which area is for you?

Tell us your situation and a specialist from the right area will get back to you, in your country and your language.

Ask the expertsDownload brochures
What we do
HELIXAFE, Cancer driver interceptionStem cell banking, Cord blood and adipose tissueBIOXPACE, Healthy longevityCELLSKILLS, Stem cells & exosomesULTRANIPT, Prenatal & neonatal genomicsNGTX, Food supplements
About Bioscience
The GroupVision & missionOur expertiseScientific boardOur specialistsPatents & certificationsAwards & recognitionsLocationsAsk the expertsClinical research & trialsBecome our partner
Brochures
Informational brochuresBrochures for patientsBrochures for physiciansWhite papers
Science & innovation News & media Shop NowTalk to an expert
Italianoالعربية中文

News & media

In-depth articles about remestemcel-L

Articles tagged In-depth articles about remestemcel-L

Articles tagged In-depth articles about remestemcel-L.

Cancer prevention

FDA Approves Ryoncil, the first MSCs Therapy for Children With Steroid-Refractory Acute GvHD

Connect with us on social

Helixafe · US